Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.33 USD | 0.00% | +13.67% | +22.69% |
Mar. 26 | North American Morning Briefing : Markets Steady -2- | DJ |
Mar. 19 | Adicet Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 3.57M | Capitalization | 191M |
---|---|---|---|---|---|
Net income 2024 * | -122M | Net income 2025 * | -125M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 53.6 x |
P/E ratio 2024 * |
-1.27
x | P/E ratio 2025 * |
-1.24
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.58% |
Latest transcript on Adicet Bio, Inc.
1 week | +13.67% | ||
Current month | -1.32% | ||
1 month | -0.48% | ||
3 months | +33.27% | ||
6 months | +63.30% | ||
Current year | +22.69% |
Managers | Title | Age | Since |
---|---|---|---|
Aya Jakobovits
FOU | Founder | 71 | 14-10-31 |
Chen Schor
CEO | Chief Executive Officer | 51 | 16-06-30 |
Brian Harvey
DFI | Director of Finance/CFO | 63 | 20-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Dubin
BRD | Director/Board Member | 70 | 20-09-14 |
Carl Gordon
CHM | Chairman | 59 | 15-08-14 |
Michael Kauffman
BRD | Director/Board Member | 64 | 21-11-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 8 M€ | +9.29% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.319 | -0.48% | 29 183 |
24-03-27 | 2.33 | +4.02% | 614,658 |
24-03-26 | 2.24 | +1.82% | 804,997 |
24-03-25 | 2.2 | +0.46% | 645,392 |
24-03-22 | 2.19 | +7.35% | 944,774 |
Delayed Quote Nasdaq, March 28, 2024 at 09:51 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.69% | 191M | |
+8.27% | 45.97B | |
+53.18% | 43.93B | |
+9.85% | 42.34B | |
-8.59% | 28.27B | |
+16.38% | 27.18B | |
-19.94% | 19.44B | |
+13.48% | 13.83B | |
+31.16% | 12.4B | |
+9.23% | 11.45B |